อ้างอิง ของ วาร์ฟาริน

  1. ↑ Holford, NH (December 1986). "Clinical Pharmacokinetics and Pharmacodynamics of Warfarin Understanding the Dose-Effect Relationship". Clinical Pharamacokinetics. Springer International Publishing. 11 (6): 483–504. doi:10.2165/00003088-198611060-00005. PMID 3542339.
  2. 1 2 3 4 "PRODUCT INFORMATION COUMADIN" (PDF). TGA eBusiness Services. Aspen Pharma Pty Ltd. 19 January 2010. สืบค้นเมื่อ 11 December 2013.
  3. ↑ Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS (May 2005). "Systematic overview of warfarin and its drug and food interactions". Archives of Internal Medicine. 165 (10): 1095–106. doi:10.1001/archinte.165.10.1095. PMID 15911722.
  4. 1 2 Ansell J; Hirsh J; Hylek E; และคณะ (2008). "Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition)". Chest. 133 (6 Suppl): 160S–198S. doi:10.1378/chest.08-0670. PMID 18574265.
  5. ↑ Holford NH. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. Clin Pharmacokinet 1986; 11: 483–504.
  6. ↑ "coumadin". The American Society of Health-System Pharmacists. สืบค้นเมื่อ 3 April 2011.
  7. 1 2 Macina, Orest T.; Schardein, James L. (2007). "Warfarin". Human Developmental Toxicants. Boca Raton: CRC Taylor & Francis. pp. 193–4. ISBN 0-8493-7229-1. Retrieved on 15 December 2008 through Google Book Search.
  8. ↑ Loftus, Christopher M. (1995). "Fetal toxicity of common neurosurgical drugs". Neurosurgical Aspects of Pregnancy. Park Ridge, Ill: American Association of Neurological Surgeons. pp. 11–3. ISBN 1-879284-36-7.
  9. ↑ Rote Liste Service GmbH (Hrsg.): Rote Liste 2017 – Arzneimittelverzeichnis für Deutschland (einschließlich EU-Zulassungen und bestimmter Medizinprodukte). Rote Liste Service GmbH, Frankfurt/Main, 2017, Aufl. 57, ISBN 978-3-946057-10-9, S. 226.